Phentermine And Topiramate 11014-0150-02
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIV
- Marketing Start
- September 17, 2012
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Phentermine Hydrochloride | 18.66 mg/1 |
| Topiramate | 92 mg/1 |
Selected Package
11014-0150-02Selected1 BAG in 1 DRUM (11014-0150-2) / 71000 CAPSULE, EXTENDED RELEASE in 1 BAG